Home » Topics » BioWorld Science

BioWorld Science
RSS

IMT-504 ameliorates neuropathic pain by modulating neuroimmune milieu

May 27, 2022

NHLBI grant supports IND-enabling studies of NMX-1 for triple-negative breast cancer

May 27, 2022

FDA awards orphan drug designation to TTI-101 for IPF

May 27, 2022

Aging mice brains have slower protein turnover, linking aging to neurodegenerative disease

May 27, 2022

Chemokine-targeting B7-H3.CAR-T cells show enhanced activity against NSCLC brain tumor lesions

May 27, 2022

SA-FasL microgels induce immune acceptance of islet transplantation

May 27, 2022

Arena Pharmaceuticals synthesizes new 5-HT2A receptor antagonists

May 27, 2022

New NFE2L2 activators identified by Sitryx Therapeutics

May 27, 2022

Lengo Therapeutics presents new EGFR and HER2 inhibitors

May 27, 2022

Engineered CAR NK cells can be an effective therapy against SARS-CoV-2 infection

May 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...